Inventor profile of:

Michael Berlin

City:

Flemington, New Jersey

Country:

United States

Published Applications:

58

Last publication date:

2026-02-26

Top Assignees for applications by Michael Berlin

The entities that hold a legal rights for patent applications filed by inventor Berlin Michael:

Recent patent applications by Berlin Michael

Michael Berlin from Flemington, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-02-26
US20260053932A1
Human necessities

COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR AND ASSOCIATED METHODS OF USE

#2 | 2025-10-09
US20250313547A1
Chemistry; metallurgy

CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS COMPRISING THE SAME

#3 | 2025-07-17
US20250228944A1
Human necessities

COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF BROMODOMAIN-CONTAINING PROTEINS

#4 | 2025-07-10
US20250223265A1
Chemistry; metallurgy

COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR

#5 | 2025-04-10
US20250114356A1
Human necessities

INDAZOLE BASED COMPOUNDS AND ASSOCIATED METHODS OF USE

#6 | 2025-02-27
US20250064945A1
Human necessities

BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE

#7 | 2025-02-20
US20250059198A1
Chemistry; metallurgy

BRM DEGRADING COMPOUNDS AND ASSOCIATED METHODS OF USE

#8 | 2025-01-30
US20250034096A1
Chemistry; metallurgy

COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR

#9 | 2024-11-21
US20240382599A1
Human necessities

EGFR PROTEOLYSIS TARGETING CHIMERIC MOLECULES AND ASSOCIATED METHODS OF USE

#10 | 2024-10-31
US20240360152A1
Chemistry; metallurgy

INDAZOLE BASED COMPOUNDS AND ASSOCIATED METHODS OF USE

#11 | 2024-10-03
US20240325547A1
Human necessities

MODULATORS OF BCL6 PROTEOLYSIS AND ASSOCIATED METHODS OF USE

#12 | 2024-07-04
US20240217962A1
Chemistry; metallurgy

TAU-PROTEIN TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE

#13 | 2024-05-16
US20240158405A1
Chemistry; metallurgy

SELECTIVE MODULATORS OF MUTANT LRRK2 PROTEOLYSIS AND ASSOCIATED METHODS OF USE

#14 | 2024-03-21
US20240091204A1
Human necessities

MODULATORS OF ALPHA-SYNUCLEIN PROTEOLYSIS AND ASSOCIATED METHODS OF USE

#15 | 2024-03-07
US20240076295A1
Chemistry; metallurgy

BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE

#16 | 2024-02-22
US20240059686A1
Chemistry; metallurgy

COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF THE ANDROGEN RECEPTOR

#17 | 2023-10-19
US20230331681A1
Chemistry; metallurgy

Compounds and methods for the targeted degradation of androgen receptor

#18 | 2023-08-24
US20230263893A1
Human necessities

Compounds and methods for the targeted degradation of bromodomain- containing proteins

#19 | 2023-06-29
US20230203030A1
Chemistry; metallurgy

Compounds and methods for the enhanced degradation of targeted proteins

#20 | 2023-06-15
US20230183209A1
Chemistry; metallurgy

CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS COMPRISING THE SAME

#21 | 2023-03-30
US20230097358A1
Chemistry; metallurgy

Indazole based compounds and associated methods of use

#22 | 2023-03-23
US20230086457A1
Human necessities

TAU-PROTEIN TARGETING PROTACS AND ASSOCIATED METHODS OF USE

#23 | 2023-03-16
US20230084249A1
Human necessities

COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR AND ASSOCIATED METHODS OF USE

#24 | 2023-03-16
US20230082997A1
Human necessities

Cereblon ligands and bifunctional compounds comprising the same

#25 | 2022-12-15
US20220395576A1
Human necessities

Modulators of BCL6 proteolysis and associated methods of use

#26 | 2022-12-01
US20220378726A1
Human necessities

Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide

#27 | 2022-10-13
US20220323457A1
Human necessities

Modulators of BCL6 proteolysis and associated methods of use

#28 | 2022-10-06
US20220315575A1
Chemistry; metallurgy

Tau-protein targeting compounds and associated

#29 | 2022-08-18
US20220259154A1
Chemistry; metallurgy

Compounds and methods for the targeted degradation of androgen receptor

#30 | 2022-05-26
US20220162163A1
Chemistry; metallurgy

ALANINE-BASED MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE

#31 | 2022-03-03
US20220064168A1
Chemistry; metallurgy

Selective modulators of mutant LRRK2 proteolysis and associated methods of use

#32 | 2021-06-24
US20210187108A1
Human necessities

Compounds and methods for the targeted degradation of bromodomain-containing proteins

#33 | 2021-06-10
US20210171470A1
Chemistry; metallurgy

Compounds and methods for the targeted degradation of androgen receptor

#34 | 2021-02-25
US20210053973A1
Chemistry; metallurgy

Substituted imidazo[1,2-c]quinazolines as A2A antagonists

#35 | 2021-02-11
US20210040044A1
Chemistry; metallurgy

COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR

#36 | 2021-01-14
US20210009528A1
Chemistry; metallurgy

Compounds and methods for the targeted degradation of androgen receptor

#37 | 2020-12-17
US20200392131A1
Chemistry; metallurgy

Compounds and methods for the enhanced degradation of targeted proteins

#38 | 2020-05-21
US20200155690A1
Human necessities

CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS COMPRISING THE SAME

#39 | 2020-05-21
US20200155689A1
Human necessities

CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS COMPRISING THE SAME

#40 | 2020-03-26
US20200095205A1
Chemistry; metallurgy

Compounds and methods for the targeted degradation of androgen receptor

#41 | 2020-03-19
US20200085793A1
Human necessities

Modulators of alpha-synuclein proteolysis and associated methods of use

#42 | 2020-02-20
US20200055825A1
Chemistry; metallurgy

Compounds and methods for the targeted degradation of androgen receptor

#43 | 2020-02-06
US20200038378A1
Human necessities

BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE

#44 | 2019-10-17
US20190315732A1
Chemistry; metallurgy

Modulators of proteolysis and associated methods of use

#45 | 2019-10-03
US20190300521A1
Chemistry; metallurgy

BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE

#46 | 2018-12-06
US20180346461A1
Chemistry; metallurgy

COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR

#47 | 2018-11-15
US20180327385A1
Chemistry; metallurgy

Aminopyrazine compounds with A2A antagonist properties

#48 | 2018-08-16
US20180228907A1
Human necessities

CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS COMPRISING THE SAME

#49 | 2018-08-02
US20180215731A1
Chemistry; metallurgy

CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS COMPRISING THE SAME

#50 | 2018-07-12
US20180193470A1
Human necessities

EGFR proteolysis targeting chimeric molecules and associated methods of use

#51 | 2018-07-12
US20180193314A1
Human necessities

Aminopyrazine compounds with A2A antagonist properties

#52 | 2018-06-28
US20180177750A1
Human necessities

Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide

#53 | 2018-05-10
US20180125821A1
Human necessities

Tau-protein targeting PROTACs and associated methods of use

#54 | 2018-04-12
US20180099940A1
Chemistry; metallurgy

Compounds and methods for the targeted degradation of androgen receptor

#55 | 2017-03-09
US20170065719A1
Human necessities

Compounds and methods for the targeted degradation of bromodomain-containing proteins

#56 | 2017-02-09
US20170037004A1
Chemistry; metallurgy

ALANINE-BASED MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE

#57 | 2016-09-22
US20160272639A1
Chemistry; metallurgy

Compounds and methods for the enhanced degradation of targeted proteins

#58 | 2016-07-07
US20160194330A1
Chemistry; metallurgy

Piperazine-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with Aantagonist properties

InventorID:

1584797 ⎘